Why vascular & autonomic assessment matters for modern practice In This Article The TM-Flow system is a non-invasive, in-office diagnostic device for independent physicians. In one short session of roughly 7 to 10 minutes it measures the ankle-brachial index, volume plethysmography, heart rate variability, and sudomotor (sweat-gland) response, giving objective data to evaluate symptomatic or…
Non-invasive cardiovascular diagnostics let primary-care practices evaluate peripheral arterial disease (PAD) and autonomic dysfunction during a standard office visit — no needles, no referral, and results in roughly 7 to 10 minutes. The CMAT Advantage system, which is FDA 510(k)-cleared, combines ankle-brachial index, pulse-volume recording, heart-rate variability, and sudomotor testing into one workflow — giving…
When a CMAT Advantage encounter is clinically indicated for a symptomatic or at-risk patient, a single 7 to 10 minute test captures three clinically distinct measurements: vascular (ABI with pulse-volume recording), cardiovagal autonomic (heart-rate variability), and sudomotor function. Each corresponds to a separate CPT code, 93923, 95921, and 95923, that may be billable under established…
Introduction Even well-intended diagnostic purchases can under-deliver when they clash with day-to-day clinical realities—think inconsistent results, stalled workflows, or reimbursement headaches. Drawing on our support and field implementation experience, HealthWright Technologies Inc has identified five pitfalls that routinely reduce clinical effectiveness. Here’s how the CMAT Advantage—our flagship CMAT device for PAD, autonomic-nerve, and sudomotor testing—solves…
For independent physicians, adding CMAT Advantage testing turns a single 7 to 10 minute, non-invasive visit into three billable diagnostic assessments: ankle-brachial index with pulse-volume recording (ABI + PVR), autonomic nervous-system analysis, and sudomotor testing. Distributed by HealthWright Technologies, the system is built on FDA-cleared component devices, pairs with a structured partnership and training program, and helps…
1 | Why “Fast, Non-Invasive & Billable” Is the New Standard Manual Doppler ABI is still guideline-recommended, yet real-world limitations such as slow workflows, operator variability, and false-negatives in calcified vessels can delay accurate diagnosis in symptomatic patients. Modern outpatient settings need diagnostics that are: HealthWright Technologies Inc satisfies all three with the CMAT Advantage,…
1. The Evolving Landscape of PAD Testing Peripheral arterial disease (PAD) affects an estimated 10 to 12 million U.S. adults over age 40 per the 2024 ACC/AHA lower extremity PAD guideline, and it is frequently underdiagnosed. Most clinics still depend on: Recent studies reveal sensitivity gaps in diabetic or calcified vessels and workflow bottlenecks that…
Purchasing a new medical device is one of the most consequential decisions an independent practice makes. This medical device purchasing guide walks physicians through a structured buying process—clinical evidence, reimbursement, training, service, and financing—and shows how the FDA-cleared CMAT Advantage from HealthWright Technologies fits each step. The goal is simple: make sure every dollar of…